NIH-funded research R01 grant

Detecting tuberculosis DNA in blood for better diagnosis

Official title: Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood

Funded at Tulane University of Louisiana · NIH-10906099 · Data updated 2026-11-12

This study is testing a new way to find tuberculosis (TB) in blood samples using a special technique that looks for tiny pieces of the bacteria's DNA, which could help people with weakened immune systems or other types of TB get diagnosed more accurately and quickly.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startAugust 11, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$726,852
NIH project number5R01AI175618-02
Project IDNIH-10906099 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suspected of having active tuberculosis, particularly those with compromised immune systems or extrapulmonary TB.

Less likely to help

Patients who have already been diagnosed with TB and are receiving effective treatment may not benefit directly from this research.

What this research studies

This research focuses on improving the diagnosis of tuberculosis (TB) by detecting cell-free DNA from the bacteria in blood samples. Current methods often struggle to accurately identify TB, especially in patients with weakened immune systems or extrapulmonary TB. By utilizing a novel CRISPR-Cas12a-based detection system, the study aims to enhance the sensitivity of TB detection, allowing for real-time monitoring of active infections and treatment responses. This approach could provide a more reliable and accessible means of diagnosing TB compared to traditional methods.

Why it matters

Potential benefit: If successful, this research could lead to faster and more accurate TB diagnoses, ultimately improving patient outcomes and treatment efficacy.

How similar studies have gone: Other research has shown promising results using CRISPR-based detection methods for various pathogens, indicating potential success for this novel approach in TB diagnosis.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Hu, Tony Y. — Tulane University of Louisiana
  • Study coordinator: Hu, Tony Y.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.